EP0686265A4 - Procedes induisant une immunite a l'arthrite de lyme et titrage colorimetrique concernant l'activite borreliacide d'antiserums - Google Patents

Procedes induisant une immunite a l'arthrite de lyme et titrage colorimetrique concernant l'activite borreliacide d'antiserums

Info

Publication number
EP0686265A4
EP0686265A4 EP94910185A EP94910185A EP0686265A4 EP 0686265 A4 EP0686265 A4 EP 0686265A4 EP 94910185 A EP94910185 A EP 94910185A EP 94910185 A EP94910185 A EP 94910185A EP 0686265 A4 EP0686265 A4 EP 0686265A4
Authority
EP
European Patent Office
Prior art keywords
antisera
methods
lyme disease
colorimetric assay
inducing immunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94910185A
Other languages
German (de)
English (en)
Other versions
EP0686265A1 (fr
Inventor
Richard T Coughlin
Jianneng Ma
Dante J Marciani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Biotech Corp
Original Assignee
Cambridge Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biotech Corp filed Critical Cambridge Biotech Corp
Publication of EP0686265A1 publication Critical patent/EP0686265A1/fr
Publication of EP0686265A4 publication Critical patent/EP0686265A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP94910185A 1993-02-26 1994-02-28 Procedes induisant une immunite a l'arthrite de lyme et titrage colorimetrique concernant l'activite borreliacide d'antiserums Withdrawn EP0686265A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2537993A 1993-02-26 1993-02-26
US25379 1993-02-26
PCT/US1994/002095 WO1994019697A1 (fr) 1993-02-26 1994-02-28 Procedes induisant une immunite a l'arthrite de lyme et titrage colorimetrique concernant l'activite borreliacide d'antiserums

Publications (2)

Publication Number Publication Date
EP0686265A1 EP0686265A1 (fr) 1995-12-13
EP0686265A4 true EP0686265A4 (fr) 2001-08-22

Family

ID=21825691

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94910185A Withdrawn EP0686265A4 (fr) 1993-02-26 1994-02-28 Procedes induisant une immunite a l'arthrite de lyme et titrage colorimetrique concernant l'activite borreliacide d'antiserums

Country Status (5)

Country Link
EP (1) EP0686265A4 (fr)
AU (1) AU689466B2 (fr)
CA (1) CA2157004A1 (fr)
NZ (1) NZ262821A (fr)
WO (1) WO1994019697A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
AU5751000A (en) 1999-06-18 2001-01-09 Brook Biotechnologies, Inc. Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
ES2298249T3 (es) 2000-08-18 2008-05-16 Research Foundation Of State University Of New York Ospa modificada de borrelia burgdorferi.
SG176451A1 (en) 2006-11-03 2011-12-29 Schering Plough Ltd Canine lyme disease vaccine
RU2013118307A (ru) 2010-09-21 2014-10-27 Стихтинг Катхолике Юниверситейт Новый способ диагностики белезни лайма с использованием теста клеточного иммунного ответа
RU2660572C1 (ru) * 2017-04-26 2018-07-06 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Красноярский Государственный Медицинский Университет Имени Профессора В.Ф. Войно-Ясенецкого" Министерства Здравоохранения Российской Федерации Способ оценки вероятности исходов эритемной формы иксодового клещевого боррелиоза

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540457A1 (fr) * 1991-10-22 1993-05-05 Symbicom Ab Améliorations dans le diagnostic et dans le prophylaxie de Borrelia burgdorferi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
US4721617A (en) * 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540457A1 (fr) * 1991-10-22 1993-05-05 Symbicom Ab Améliorations dans le diagnostic et dans le prophylaxie de Borrelia burgdorferi

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS, 1 January 1900, Philadelphia, PA, US; abstract no. 1991-381408, HUM W T, ET AL: "CLONING EXPRESSION AND PURIFICATION OF BORRELIA-BURGDORFERI OSPA A CANDIDATE VACCINE FOR LYME DISEASE" XP002170803 *
See also references of WO9419697A1 *
W.T. HUM ET AL.: "CLONING EXPRESSION AND PURIFICATION OF BORRELIA BURGDORFERI OSPA A CANDIDATE VACCINE FOR LYME DISEASE.", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY OF MICROBIOLOGY 1991, vol. 91, 5 May 1991 (1991-05-05), Dallas TX USA, pages 124 *

Also Published As

Publication number Publication date
CA2157004A1 (fr) 1994-09-01
WO1994019697A1 (fr) 1994-09-01
NZ262821A (en) 1997-03-24
EP0686265A1 (fr) 1995-12-13
AU689466B2 (en) 1998-04-02
AU6272894A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
ZA908446B (en) Use of a benzodiazepine and phenylpyrrylketone derivative
EG19845A (en) Unitized sanitary napkin
ZA896921B (en) Unitized sanitary napkin
EP0394393A4 (en) Parathion hydrolase analogs and methods for production and purification
GB2227998B (en) A water purifying device
GB8817710D0 (en) Method of assay
GB8818453D0 (en) Devices for assisting people to carry loads
EP0686265A4 (fr) Procedes induisant une immunite a l'arthrite de lyme et titrage colorimetrique concernant l'activite borreliacide d'antiserums
ZA932315B (en) Shaped absorbent structure and method of forming a shaped absorbent structure
GB2204615B (en) A honeycomb type of structure for interment of human remains
IL90396A0 (en) Method of assay
EP0424316A3 (en) Purification of 2-aryl-2h-benzotriazoles
HU906906D0 (en) Utilization of a benzodiazepine derivative and a phenyl-pyrrile-ketone derivative
GB8723889D0 (en) Destruction of hydrocarbons
ZA905125B (en) Use of retinoids
GB8918144D0 (en) Improvements in or relating to a method of degredation of excrement
PL327172A1 (en) Method of purifying recombined human interleukin - 8
GB9307250D0 (en) A method adaptable to the screening of substances for therapeutic activity
GB8708560D0 (en) Street dog toilet cleansing system
RO101217B1 (en) N-hexane purification method
GB2226327B (en) Purification of 1-amino-2-chloro-4-hydroxyanthraquinone
PL296576A1 (en) Method of purifying feldspar meal
RO102731B1 (en) Purifying method of diaryl-carbonates
TW333056U (en) Improved structure of a nursing bottle
CS165188A1 (en) Method of waste liquidation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950826

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010710

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/569 A, 7A 61K 39/02 B, 7A 61K 39/39 B, 7C 12Q 1/18 B

17Q First examination report despatched

Effective date: 20030415

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030826